One of the mechanisms by which PPARs act to control cancer progression is to affect the NF-κB signaling pathway, or its upstream pathways, such as the Toll-like receptor 4 (TLR4) signaling pathway [35,36]. This evidence concerns the gene TLR4 and cancer.